Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Roth MKM Initiates Coverage On Aspen Aerogels with Buy Rating, Announces Price Target of $22

Author: Benzinga Newsdesk | March 06, 2024 06:56am
Roth MKM analyst Chip Moore initiates coverage on Aspen Aerogels (NYSE:ASPN) with a Buy rating and announces Price Target of $22.

Posted In: ASPN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist